Analysis of the tissue of the xenografts of non-small-cell lung cancer at the end of the study showed a slightly but not significantly lower protein level of VEGF for the L-Cis/MF treatment versus the control (Figure 8). The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.